SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as retail investors draw comparisons to the 2021 short squeeze, with some hoping it will mirror the recent volatility in $BYND. Community members discuss call options, potential buybacks, and the possibility of a gamma squeeze. Despite the positive price action, some remain skeptical, citing weak fundamentals and high volatility.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer's stock is trending due to a revised revenue outlook, citing design win upgrades impacting delivery schedules and shifting some revenue to the next quarter. Despite reiterating a strong fiscal year forecast, the community is actively debating the impact of the news, management's credibility, and potential trading strategies given the volatility. Some investors express frustration with the company's leadership and consistency in meeting expectations, while others view the dip as a buying opportunity amidst robust AI demand.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending as it joins the S&P 100, sparking community discussion about the company finally breaking the $100 mark. Bullish sentiment is fueled by strong financials, autonomous vehicle developments, and a potential for further gains, although some traders express frustration with past price action. Many are closely watching if Uber can maintain momentum and solidify its position.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as investors anticipate the upcoming GTC conference, where new products and partnerships are expected to be revealed, possibly driving the stock toward $190. Bullish sentiment is fueled by optimism surrounding potential deals and positive economic data, while some traders are wary of potential pullbacks and China-related headwinds. The community is actively discussing potential price movements and technical analysis, with strong opinions on both bullish and bearish scenarios.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is trending as investors discuss its strategic partnership with Palantir to enhance enterprise AI capabilities and its potential role in the growing AI sector, particularly regarding data centers and fiber optic infrastructure. Community members are also anticipating upcoming earnings and speculating on potential acquisitions. The broader discussion revolves around Lumen's transformation and its position in the evolving tech landscape.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum ($QBTS) is trending amid speculation that the Trump administration might take an equity stake in quantum computing firms, fueling significant community discussion and trading volume. Despite some contradictory reports and denials of ongoing negotiations, chatter persists around the potential for government investment to boost the sector and counter China's quantum initiatives. Traders are actively debating the validity of news sources and the potential impact on the stock's future.

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Ventyx Biosciences Inc

Ventyx Biosciences is trending following positive Phase 2 trial results for its Parkinson's drug, showing safety and target engagement. The community is buzzing about potential analyst upgrades and buyout scenarios, particularly by Sanofi given their existing relationship. Discussions also involve the drug's broader applicability and market potential beyond Parkinson's.

Bleichroeder Acquisition Corp. I is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Andrew Stephen Gundlach and Michel Combes on June 24, 2024 and is headquartered in New York, NY.

Bleichroeder Acquisition Corp. I - Ordinary Shares - Class A

Bleichroeder Acquisition Corp I

Bleichroeder Acquisition Corp I (BACQ) is trending due to increased interest following bullish sentiment from Citron Research, highlighting the company's merger with Merlin Labs, an AI autonomous flight technology firm, and existing government contracts. The community is actively discussing the potential for significant gains, particularly focusing on the undervalued rights and the company's partnerships within the aerospace and defense sectors. Some are drawing comparisons to other AI-related SPACs and anticipating a substantial price increase.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending amid news of a partnership with Anthropic to integrate AI models into its software, seen as a boost to enterprise AI capabilities. The community is discussing IBM's leadership in quantum computing and AI, as well as its potential for long-term growth, though some remain cautious. Recent analyst ratings and price target adjustments are also contributing to the conversation around the stock.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amid speculation surrounding a potential sale or strategic partnership, possibly involving major players like SpaceX or Amazon, following comments from the chairman about a potential multi-billion dollar deal. Community discussions revolve around the valuation of Globalstar's spectrum and assets, comparing it to recent transactions in the satellite communications sector, and the potential impact of Apple's involvement and the company's expansion in IoT.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced it will share initial topline safety, tolerability and early efficacy...

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates

Repare Therapeutics (RPTX) delivered earnings and revenue surprises of +30.36% and -95.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Repare Therapeutics saw its stock climb in after-hours trading Tuesday after disclosing a global licensing deal with Switzerland-based Debiopharm International for lunresertib, a first-in-class PKMYT1 inhibitor aimed at treating hard-to-tackle solid tumors.The agreement gives Repare a $10 million upfront boost, with the potential to bring in up to $257 million more through clinical, regulatory, and commercial milestones, including $5 million in possible near-term payouts.&nbsp;Repare will also earn single-digit royalties on future global net sales.<a href="https://stocktwits.com/symbol/RPTX">RPTX’s stock</a> closed Monday down 8.9% at $1.43, but rebounded 22.4% in after-hours trading to $1.75.The agreement builds on an existing collaboration between the two companies that explored the synergy of lunresertib with Debiopharm’s Debio 0123, a selective WEE1 inhibitor.&nbsp;As part of the deal, Debiopharm will take over sponsorship of the Mythic trial and assume all development activities related to lunresertib moving forward.Repare remains on track to report initial data from two ongoing Phase 1 trials—the Lions trial for its PLK4 inhibitor RP-1664 and the Polar trial for its Polθ ATPase inhibitor RP-3467—in the second half of 2025.As of March 31, Repare had $124.2 million in cash and marketable securities on hand, which it says should be enough to fund its operations through 2027.&nbsp;The company reported a net loss of $0.71 per share in the first quarter, swinging from a profit of $0.30 per share in the same period last year.&nbsp;Repare has said it continues to explore strategic alternatives across its pipeline, including out-licensing and partnerships.On Stocktwits, retail sentiment for RPTX was ‘extremely bullish’ amid ‘extremely high’ message volume.One Stocktwits user expressed optimism about their position in the stock, noting an entry point at $1.62 with 10,000 shares and indicating confidence heading into the pre-market session.&nbsp;<stembedurl>https://stocktwits.com/TheThroatSlasher/message/621090644</stembedurl>Another user encouraged buying, citing the stock’s after-hours gain.<stembedurl>https://stocktwits.com/Eelmm842/message/621076455</stembedurl>RPTX’s stock has risen 8.3% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Repare Therapeutics (RPTX) disclosed a global licensing deal with Switzerland-based Debiopharm International. (Photo credit: Getty Images)

Repare Therapeutics Jumps After Hours On $267M Global Licensing Deal With Debiopharm; Retail Traders Rush In

Repare Therapeutics saw its stock climb in after-hours trading Tuesday after disclosing a global licensing deal with Switzerland-based Debiopharm International for lunresertib

Equity

The deal builds on an existing collaboration around lunresertib and hands development control to Debiopharm, allowing Repare to focus on its Phase 1 trials for RP-1664 and RP-3467.

Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions

Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced a re-alignment of resources and a re-prioritization of its...

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options PR Newswire VANCOUVER, BC, Dec. 23, 2024 Issued on...

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial

Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today reported positive data from its MYTHIC Phase 1 gynecologic expansion...

Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial

Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced it will host a conference call and live webcast to present the...

Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib

Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced a Cooperative Research and Development Agreement (CRADA) has been...

Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results

Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today reported financial results for the third quarter ended September 30, 2024...

Repare Therapeutics Announces Updated Positive Safety and Tolerability Results from the Phase 1 MYTHIC Clinical Trial

Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today presented updated data highlighting the benefits of its individualized...

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.

RPTX
Repare Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RPTX News

RPTXRepare Therapeutics Inc